Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology

被引：240

作者：

Mithoowani, Hamid ^{[1
]}

Febbraro, Michela ^{[2
]}

机构：

[1] Grand River Reg Canc Ctr, 835 King St W, Kitchener, ON N2G 1G3, Canada

[2] Hamilton Hlth Sci Ctr, Juravinski Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada

来源：

CURRENT ONCOLOGY | 2022年 / 29卷 / 03期

关键词：

non-small cell lung cancer; lung cancer; screening; immunotherapy; iRAE; iRAEs; CAGPO; Canadian Association of General Practitioners in Oncology; ALK; EGFR; K-RAS; KRAS; OPEN-LABEL; SINGLE-ARM; CHEMOTHERAPY; OSIMERTINIB; CHEMORADIOTHERAPY; MULTICENTER; CRIZOTINIB; MUTATIONS; NIVOLUMAB; SELECTION;

D O I：

10.3390/curroncol29030150

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer is the leading cause of cancer death in Canada and a significant cause of morbidity for patients and their loved ones. There have been rapid advances in preventing, screening and treating this disease. Here, we present a contemporary review of treatment of non-small cell lung cancer in Canada based on current best practices. The focus of this review is to highlight recent data in screening for lung cancer, management of patients with early and locally-advanced non-small cell lung cancer, as well as management of patients with metastatic disease. There is a special focus on the incorporation of immunotherapy into practice and its associated toxicities.

引用

页码：1828 / 1839

页数：12

共 66 条

[51] Epidermal growth factor receptor mutations in lung cancer [J].

Sharma, Sreenath V. ;

Bell, Daphne W. ;

Settleman, Jeffrey ;

Haber, Daniel A. .

NATURE REVIEWS CANCER, 2007, 7 (03) :169-181

[52] First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer [J].

Shaw, Alice T. ;

Bauer, Todd M. ;

de Marinis, Filippo ;

Felip, Enriqueta ;

Goto, Yasushi ;

Liu, Geoffrey ;

Mazieres, Julien ;

Kim, Dong-Wan ;

Mok, Tony ;

Polli, Anna ;

Thurm, Holger ;

Calella, Anna M. ;

Peltz, Gerson ;

Solomon, Benjamin J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21) :2018-2029

[53] Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial [J].

Shaw, Alice T. ;

Solomon, Benjamin J. ;

Chiari, Rita ;

Riely, Gregory J. ;

Besse, Benjamin ;

Soo, Ross A. ;

Kao, Steven ;

Lin, Chia-Chi ;

Bauer, Todd M. ;

Clancy, Jill S. ;

Thurm, Holger ;

Martini, Jean-Francois ;

Peltz, Gerson ;

Abbattista, Antonello ;

Li, Sherry ;

Ou, Sai-Hong Ignatius .

LANCET ONCOLOGY, 2019, 20 (12) :1691-1701

[54] Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer [J].

Shaw, Alice T. ;

Ou, Sai-Hong I. ;

Bang, Yung-Jue ;

Camidge, D. Ross ;

Solomon, Benjamin J. ;

Salgia, Ravi ;

Riely, Gregory J. ;

Varella-Garcia, Marileila ;

Shapiro, Geoffrey I. ;

Costa, Daniel B. ;

Doebele, Robert C. ;

Long Phi Le ;

Zheng, Zongli ;

Tan, Weiwei ;

Stephenson, Patricia ;

Shreeve, S. Martin ;

Tye, Lesley M. ;

Christensen, James G. ;

Wilner, Keith D. ;

Clark, Jeffrey W. ;

Iafrate, A. John .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21) :1963-1971

[55] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer [J].

Soria, J. -C. ;

Ohe, Y. ;

Vansteenkiste, J. ;

Reungwetwattana, T. ;

Chewaskulyong, B. ;

Lee, K. H. ;

Dechaphunkul, A. ;

Imamura, F. ;

Nogami, N. ;

Kurata, T. ;

Okamoto, I. ;

Zhou, C. ;

Cho, B. C. ;

Cheng, Y. ;

Cho, E. K. ;

Voon, P. J. ;

Planchard, D. ;

Su, W. -C. ;

Gray, J. E. ;

Lee, S. -M. ;

Hodge, R. ;

Marotti, M. ;

Rukazenkov, Y. ;

Ramalingam, S. S. ;

Boyer, Michael ;

Lee, Chee ;

Hughes, Brett ;

O'Byrne, Kenneth ;

Briggs, Peter ;

Milward, Michael ;

John, Thomas ;

Demedts, Ingel ;

Vansteenkiste, Johan ;

Bustin, Frederique ;

Barrios, Carlos Henrique ;

Timcheva, Constanta ;

Butts, Charles ;

Goss, Glenwood ;

Juergens, Rosalyn ;

Leighl, Natasha ;

Cheng, Susanna ;

Burkes, Ronald ;

Zhou, Caicun ;

Zhang, Helong ;

Shu, Yongqian ;

Cheng, Ying ;

Zhou, Qing ;

Li, Wei ;

Feng, Guosheng ;

He, Yong .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02) :113-125

[56] Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer [J].

Temel, Jennifer S. ;

Greer, Joseph A. ;

Muzikansky, Alona ;

Gallagher, Emily R. ;

Admane, Sonal ;

Jackson, Vicki A. ;

Dahlin, Constance M. ;

Blinderman, Craig D. ;

Jacobsen, Juliet ;

Pirl, William F. ;

Billings, J. Andrew ;

Lynch, Thomas J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :733-742

[57] Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON) [J].

van Iersel, Carola A. ;

de Koning, Harry J. ;

Draisma, Gerrit ;

Mali, Willem P. T. M. ;

Scholten, Ernst Th. ;

Nackaerts, Kristiaan ;

Prokop, Mathias ;

Habbema, J. Dik. F. ;

Oudkerk, Mathijs ;

van Klaveren, Rob J. .

INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (04) :868-874

[58] Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B [J].

Vokes, Everett E. ;

Herndon, James E., II ;

Kelley, Michael J. ;

Cicchetti, M. Giulia ;

Ramnath, Nithya ;

Neill, Harvey ;

Atkins, James N. ;

Watson, Dorothy M. ;

Akerley, Wallace ;

Green, Mark R. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1698-1704

[59] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer [J].

Vyse, Simon ;

Huang, Paul H. .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)

[60] Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis [J].

Wang, Daniel Y. ;

Salem, Joe-Elie ;

Cohen, Justine V. ;

Chandra, Sunandana ;

Menzer, Christian ;

Ye, Fei ;

Zhao, Shilin ;

Das, Satya ;

Beckermann, Kathryn E. ;

Ha, Lisa ;

Rathmell, W. Kimryn ;

Ancell, Kristin K. ;

Balko, Justin M. ;

Bowman, Caitlin ;

Davis, Elizabeth J. ;

Chism, David D. ;

Horn, Leora ;

Long, Georgina V. ;

Carlino, Matteo S. ;

Lebrun-Vignes, Benedicte ;

Eroglu, Zeynep ;

Hassel, Jessica C. ;

Menzies, Alexander M. ;

Sosman, Jeffrey A. ;

Sullivan, Ryan J. ;

Moslehi, Javid J. ;

Johnson, Douglas B. .

JAMA ONCOLOGY, 2018, 4 (12) :1721-1728

← 1 2 3 4 5 6 7 →